MYC overexpression with its prognostic and clinicopathological significance in breast cancer.

导出 OA

翻译打印收藏纠错

第一作者： Jingkun,Qu

第一单位： The Second Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.

作者： Jingkun,Qu ^[1] ; Xixi,Zhao ^[2] ; Jizhao,Wang ^[1] ; Xu,Liu ^[1] ; Yan,Yan ^[1] ; Lin,Liu ^[1] ; Hui,Cai ^[1] ; Hangying,Qu ^[3] ; Ning,Lu ^[4] ; Yuchen,Sun ^[4] ; Feidi,Wang ^[5] ; Jiansheng,Wang ^[2] ; Jia,Zhang ^[1]

作者单位： The Second Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China. ^[1] Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China. ^[2] Department of Vascular Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China. ^[3] Department of Oncological Surgery, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China. ^[4] Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China. ^[5]

关键词 MYC breast cancer clinicopathology meta-analysis prognosis

DOI 10.18632/oncotarget.21501

PMID 29212204

发布时间 2022-03-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交